|
Match
|
Document |
Document Title |
|
|
5026721 |
Amino acid nutritional supplement and regimen for enhancing physical performance through sound nutrition
An amino acid nutritional supplement and administration regimen for enhancing physical performance through sound nutrition is provided. The amino acid supplement comprises a mixture of biologically...
|
|
|
5023268 |
3-phenoxy (or phenylthio)-cyclopentanecarbonylamino acid analogues
Compounds related to 3-phenoxy (or phenylthio) cyclopentanecarbonylamino acid, processes for their preparation, and treating agents for cerebral edema containing the compounds as active ingredients...
|
|
|
5019594 |
Method for decreasing appetite
A composition for decreasing appetite comprising an indirect-acting sympathomimetic drug and tyrosine or a tyrosine precursor. The drug may be phenylpropanolamine, amphetamine, or ephedrine. The...
|
|
|
5015654 |
Pharmaceutical compositions
A pharmaceutical composition which comprises a mixture of an alpha-2 adrenoceptor antagonist, preferably idazoxan, or a pharmaceutically acceptable salt thereof, and either a catecholamine...
|
|
|
5013719 |
Method of effecting immunosuppression
This invention relates to a method of effecting immunosuppression in a patient in need thereof, comprising co-administering to said patient an effective amount of an immunosuppressive agent,...
|
|
|
5006559 |
Method of use of branched-chain amino acids infusions to influence appetite
This invention is a method of influencing voluntary food intake of patients receiving parenteral infusions, by adding branched-chain amino acids to the infusion solution. The branched-chain amino...
|
|
|
4996234 |
HMG-CoA reductase inhibitors
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened...
|
|
|
4994492 |
Treatment of melanoma using N,N-dimethylglycine
This invention relates to a method for inhibiting the metastasis or formation of a melanoma tumor by treating the patient with an effective amount of N,N-Dimethylglycine.
|
|
|
4988515 |
Cardioplegic solution
An improved amino acid enriched cardioplegic solution adapted for use in preventing and treating heart muscle damage due to regional ischemia. The solution includes a calcium ion concentration of...
|
|
|
4987123 |
Compositions useful for the treatment and/or prevention of hepatic disorders, and their pharmaceutical use
A composition, comprising L-alanine or a salt thereof, L-glutamine or a salt thereof, and an oligopeptide containing either a L-alanine residue or a L-glutamine residue, or both, is disclosed. A...
|
|
|
4980176 |
Preservative compositions and uses thereof
Compositions of matter containing a compound which is a member selected from the group consisting of hydroxymethylaminoacetic acids, its salts and lower alkyl esters, and one or more...
|
|
|
4975281 |
Anti-ulcer composition
In accordance with the present invention a novel oral composition and method of using same for the treatment of ulcers and other gastrointestinal disorders is disclosed. The composition comprises...
|
|
|
4973553 |
Salt or organogermanium compound and medicine containing the same
The present invention provides salts of organogermanium compounds expressed by the following Formual (a): ##STR1## (wherein M denotes an oxygen or sulfur atom; and R 1 , R 2 , R 3 , and R 4 may be...
|
|
|
4971987 |
New carbacycline, process for their production and their use as a drug
The invention also relates to carbacyclin derivatives of general formula I' ##STR1## wherein R 9 is an alkyl group of 1-10 carbon atoms or the group --CC--(CH 2 ) m --R 6 wherein m is 1 to...
|
|
|
4963529 |
Stable growth hormone releasing factor preparation
Growth hormone releasing factor (GRF) preparation which is excellent in stablity by having human serum albumin or glycine incorporated therein, with or without buffer. An amount of human serum...
|
|
|
4957938 |
Nutritional formulation for the treatment of renal disease
A novel nitritional formulation comprising mixtures of mixed salts formed between branched-chain α-keto-acids and basic L-amino acid is disclosed which provides optimal nutrition when consumed...
|
|
|
4937234 |
Minerals in bioavailable form
A soluble mineral in bioavailable form is formed from a mineral salt of a carboxylic acid derivative of a pentose or hexose such as zinc gluconate and an amino acid having the ability of stabilize...
|
|
|
4935429 |
Method of treating psychostimulant addiction
A method of treating psychostimulant abuse with a therapeutically effective amount of a dopamine agonist.
|
|
|
4935450 |
Cancer therapy system for effecting oncolysis of malignant neoplasms
A method for effecting oncolysis, regression, and control of malignant neoplasms in humans and other mammals without adverse effects on normal body cells is described. An ATP-availability depressor...
|
|
|
4933367 |
Carboxylic acid derivatives, processes for the preparation thereof, the use thereof, and pharmaceutical compositions which contain these compounds
This invention relates to carboxylic acid derivatives and their use thereof. The compounds are useful in treatment of various diseases such as diabetes, prediabetic conditions, adipositas ailments...
|
|
|
4920098 |
Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
A method is provided for individuals under treatment for or at risk of atherosclerotic, vascular, cardiovascular, and/or thrombotic disease by administering a composition which comprises a protein...
|
|
|
4916151 |
Method of treating parkinson's syndrome
Novel nonaromatic fluoroallylamines are potent MAO inhibitors and at low dose selectively inhibit MAO-B. They are useful in the treatment of depression and co-administration with L-dopa and...
|
|
|
4910225 |
Locally administrable therapeutic composition for inflammatory disease
This invention relates to a locally administrable therapeutic composition for inflammatory disease which is characterized by comprising benzoylphenylacetic acid of the formula ##STR1## (wherein R...
|
|
|
4906662 |
Phenol derivatives, their preparation and the use thereof
Disclosed are phenol derivatives of the formula ##STR1## wherein R 1 is a substituted phenyl group, R 2 and R 3 are C 1 -C 6 alkyl group and of the formula ##STR2## wherein R 8 , R 9 and R 10...
|
|
|
4898879 |
Nurtitional composition for management of hepatic failure
Nutritional compositions for management of hepatic failure are improved by eliminating certain ammonotelic amino acids and reducing the proportion of essential ammonotelic amino acids. A...
|
|
|
4891356 |
Proteinase inhibitors for treatment of gastrointestinal ulcer disease
A method of treating gastrointgestinal ulcer disease is provided which involves administration of a proteinase inhibitor or analogue to patients suffering from same. Of particular interest is the...
|
|
|
4885312 |
Method for enhancing the effect of indirect-acting sympathomimetic amines
Tyrosine or a tyrosine precursor is administered concomitantly with an indirect-acting sympathomimetic amine drug to increase the level of norepinephrine that can be released in sympathetic neuron...
|
|
|
4882324 |
Essentially pure acid hydroxyl ligand aluminum complexes and their preparation
Essentially pure acid hydroxyl ligand aluminum complexes useful as antacids are prepared by first reacting an acid hydroxyl ligand with an aluminum alkoxide under anhydrous conditions to form an...
|
|
|
4873263 |
Rectally absorbable form of L-dopa
The invention relates to compositions and methods of enhancing rectal absorption of L-dopa via the formation of an ester prodrug and optionally with a decarboxylase inhibitor.
|
|
|
4871550 |
Nutrient composition for athletes and method of making and using the same
A unique, chemically-defined nutrient composition is disclosed which can enable stressed, catabolic, marathon athletes to achieve superior performance. The diet provides substantially all of the...
|
|
|
4868213 |
Disinfectant and cleansing compositions
A disinfectant and cleansing composition is provided which contains as primary active ingredient an alkali metal salt of a hydroxy alkyl amine-substituted carboxylic acid, e.g., sodium dihydroxy...
|
|
|
4863962 |
D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
The present invention is directed to a method of treating Parkinson's disease. More particularly, the present invention utilizes D-DOPA or the racemic mixture of D,L-DOPA, or pharmaceutically...
|
|
|
4863901 |
Use of growth hormone for nitrogen retention under hypocaloric conditions
A method and composition for effecting protein accretion in an animal. The composition comprises a hypocaloric dietary component comprising a metabolizable source of nitrogen, carbohydrate, and,...
|
|
|
4863926 |
Nitro aliphatic compounds, process for preparation thereof and use thereof
New nitro aliphatic compounds useful as antithrombotic and antihypertensing agents are disclosed.
|
|
|
4859452 |
Methods for the reduction of difluoromethylornithine associated toxicity
Disclosed are total parenteral nutrition formulations which include essential amino acids in combination with either arginine or ornithine, for use in the detection of recurrent malignant disease...
|
|
|
4855289 |
Combination of two active substances
The invention concerns the use of a compound with diuretic properties and of a magnesium supplementation in the form of magnesium monoaspartate hydrochloride, magnesium oxide, magnesium hydroxide...
|
|
|
4853398 |
Leukotriene antagonists and use thereas
This invention provides benzene derivatives which are leukotriene antagonists, formulations of those derivatives, and a method of using those derivatives for the treatment of conditions...
|
|
|
4847083 |
Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
Decubitus ulcers are treated with a preconditioning aqueous medium and then with a non-systemic basic ointment. The aqueous medium comprises an aqueous solution of pyridoxine hydrochloride, zinc...
|
|
|
4845125 |
Chemolytic EDTA-citric acid composition for dissolution of calculi
An improved composition for dissolution of renal calculi is disclosed. The composition includes citric acid, preferably at about 10 to about 15% by weight, and an effective amount of a...
|
|
|
4842734 |
Essentially pure acidic amine ligand aluminum complexes and their preparation
Essentially pure acidic amine ligand aluminum complexes useful as antacids are prepared by first reacting an acidic amine ligand with an aluminum alkoxide under anhydrous conditions to form an...
|
|
|
4837219 |
Medication for Alzheimer's disease
A medication for Alzheimer's disease is provided and consists of six ingredients mixed into fruit juice, to bring about improvements in an Alzheimer's disease patient. The ingredients are Choline...
|
|
|
4822773 |
Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
Choline ester salts are used as drug absorption enhancing agents for orally and rectally administered drugs.
|
|
|
4818516 |
Method of nutritional assessment and therapy
A method for assessing nutritional status and treating a nutritional disorder in a subject. The subject's intracellular status is monitored by measuring selected intracellular amino acids and at...
|
|
|
4816472 |
Derivatives of 19,20-Bis-nor-prostanoic acid with antiulcer and anorectic activity, process for their preparation and pharmaceutical compositions thereof
9-amino-19,20-bisnorprostanoic acids are useful for depressing appetite.
|
|
|
4810497 |
Pharmaceutical compositions
Presenile and senile dementia, in particular Alzheimer's disease, can be combated or alleviated by administration of an effective amount of a physiologically acceptable lithium compound and an...
|
|
|
4808631 |
Aromatic acid derivatives
Use of compounds of the formula ##STR1## wherein R 1 , R 2 , R 3 , R 4 and R 5 , independently are hydrogen, alkyl, or C 3 -7 -cycloalkyl or two adjacent residues R 1 to R 5 taken together with...
|
|
|
4804674 |
Vaginal pharmaceutical composition
A vaginal pharmaceutical composition having sperm motility enhancing activity comprising a sperm motility enhancing amount of at least one sperm motility enhancing amino acid or amino acid salt in...
|
|
|
4792549 |
Composition of amino acids
A composition of amino acids which can be orally administrated to patients of hepatic and renal diseases for increasing serum albumin, haemoglobin and branched amino acids in serum and for...
|
|
|
4780475 |
Preparation for the prevention of catabolism
Prevention of catabolism and increasing protein synthesis in a subject undergoing stress with compositions containing isoleucine, leucine and valine.
|
|
|
4776976 |
O/W type emulsion composition
A composition comprising; (A) a basic amino acid salt of a higher aliphatic phosphate represented by the following formula (I): ##STR1## in which R 1 is an alkyl or alkenyl group having from 12 to...
|